{"id":"NCT05393037","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-07-13","primaryCompletion":"2023-07-13","completion":"2024-01-25","firstPosted":"2022-05-26","resultsPosted":"2024-07-25","lastUpdate":"2025-03-30"},"enrollment":313,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"V116","otherNames":["Pneumococcal 21-valent Conjugate Vaccine"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"PCV15","otherNames":["VAXNEUVANCE™;"]},{"type":"BIOLOGICAL","name":"PPSV23","otherNames":["PNEUMOVAX™23"]},{"type":"BIOLOGICAL","name":"PCV15 - Part B","otherNames":["VAXNEUVANCE™"]}],"arms":[{"label":"V116 + Placebo","type":"EXPERIMENTAL"},{"label":"PCV15 + PPSV23","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the safety, tolerability, and immunogenicity of a pneumococcal 21-valent conjugate vaccine (V116) in persons living with human immunodeficiency virus (HIV), for the prevention of pneumococcal disease caused by the serotypes in the vaccine.","primaryOutcome":{"measure":"Percentage of Participants With Solicited Injection-site AEs From Day 1 Through Day 5 Postvaccination in Part A","timeFrame":"Up to 5 days after each vaccination in Part A","effectByArm":[{"arm":"V116 + Placebo (Part A), PCV15 (Part B)","deltaMin":3.9,"sd":null},{"arm":"PCV15 + PPSV23 (Part A)","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":17},"locations":{"siteCount":20,"countries":["United States","Belgium","Chile","France","South Africa","Thailand"]},"refs":{"pmids":[],"seeAlso":["https://www.merckclinicaltrials.com/"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":155},"commonTop":["Injection site pain","Fatigue","Headache","Myalgia","Injection site swelling"]}}